+91-8668442535

Cardiac POC Testing Devices and Kits Market By Device Type (Cardiac POC testing analyzer, Cardiac POC test kits (Cardiac Troponin Biomarker Test, Myoglobin Biomarker Test, Brain Natriuretic Peptide (BNP) Test Myoglobin Biomarker Test, Creatine Kinase Myoglobin (CK-MB) Biomarker Test, Hybrid test))- Growth, Future Prospects and Competitive Analysis, 2017 - 2025

The evolution of cardiac point-of-care testing resulting from the application of innovative technology in medical science for improved disease diagnosis further leads to the improvement of cardiac health. Coronary artery diseases and ischemic heart diseases are on the rise, causing a number of deaths worldwide with an increasing geriatric population and changing lifestyle patterns. The rising trend of cardiac disorders drives the demand for POC testing devices for rapid and accurate health diagnosis. The diagnostic approach to acute coronary syndrome involves the detection of elevated levels of certain biomarkers like cardiac troponin, creatine kinase (CK), CK-myocardial band (MB), B-type natriuretic peptide (BNP), and myoglobin and helps to make appropriate treatment decisions.

The increased popularity of cardiac POCT devices can be attributed to their short processing time and ability to deliver accurate results. The overall growth of the cardiac POC testing devices and kits market is a result of decreased turnaround time, increased patient safety, and patient satisfaction. A shortage of trained health personnel in laboratories and a wide range of Clinical Laboratory Improvement Amendments (CLIA)-waived POC testing devices contribute to major growth in the cardiac POC testing devices and kits market.

Technologically advanced and innovative products boost the growth of the market for cardiac POC testing devices and kits. However, being a comparatively more expensive approach than traditional laboratory testing, the growth of the market for cardiac POC testing devices and kits might be hampered. Stringent regulatory guidelines for POC devices and pricing pressure among major manufacturers might restrain the cardiac POC testing devices and kits market globally. This report provides an overview of the global market for cardiac POC testing devices and kits, broken down by device type and geographic distribution. On the basis of device type, the cardiac POC testing kit was predicted to dominate the market owing to its lower price and surging demand among health providers, and the market size and forecast for each segment are presented for 2015–2025 along with respective CAGRs for the forecast duration of 2017–2025.

The report titled "Cardiac POC Testing Devices and Kits Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" is to provide company executives, investors, developers, and industry participants with profound analysis to take strategic initiatives and business decisions related to the present market scenario and future predictions of the global cardiac POC testing devices and kits market. This report provides a market trend for current and future cardiac POC testing devices and kits, as well as a detailed analysis of market size and forecast. Global health concerns, increasing research expenditure, advanced technology, and product innovation strongly boost the growth of the cardiac POC testing devices and kits market.

Geographically, the cardiac POC testing devices and kits market is segmented into five major regions and chief region-level markets as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

This research study encompasses market size and forecast data for every considered geographical market, including constituent regions and countries, for the period of 2015–2025 and presents CAGRs for the forecast period of 2017–2025.

This report also consists of qualitative factors that affect market dynamics, such as market drivers, restraints, and opportunities, in order to attain an understanding of the global market trends of cardiac POC testing devices and kits. A detailed explanation of major agreements, mergers and acquisitions activities, joint ventures, partnerships, collaborations, and market attractiveness assessment has been mentioned in the study report. Furthermore, Nexus Dx, Inc., LifeSign LLC, Alfa Scientific Designs, Inc., Spectral Diagnostics, Roche Diagnostics International Ltd., American Screening Corporation, Inc., Alere, Abbott, Siemens Ltd., Mitsubishi Chemical, BioMérieux, Inc., and Nano-Ditech Corp. are profiled in this report.

The cardiac POC testing devices and kits market is categorized on the basis of device types, and the categories are:

  • Cardiac POC testing analyzer
  • Cardiac POCT test kits
  • Cardiac Troponin Biomarker Test
  • myoglobin biomarker test
  • Brain Natriuretic Peptide (BNP) Test
  • Creatine Kinase Myoglobin (CK-MB) Biomarker Test
  • D-Dimer Test
  • Hybrid Test

Cardiac POC test kits are estimated to dominate the cardiac POC testing device and kit market due to their lower price and increasing trend of usage. Biochemical markers have a crucial role in the clinical diagnosis of medical conditions such as acute myocardial infarction or cardiac injury when traditional methods fail to detect them. The concept of cardiac point-of-care diagnosis has been evolving with time as a result of faster, more accurate, and more reliable clinical outcomes. Cardiac POC testing devices provide the advantage of lowering the delay in sample transportation, processing, and data entry, which further boosts the POC testing device market's growth. Options of easy handling, portability of the device, rapid results of detection, and a reduced period of hospital stay facilitate the growth of the cardiac POC biomarker testing device. Cardiac analyzers are predicted to witness significant growth as a result of technologically advanced device features like barcode scanners, simple operation, and low-maintenance electrodes.

Geographically, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa account for the global market for cardiac POC testing devices and kits.North America emerged as the leading region in the cardiac POC testing devices and kits market with steady growth owing to developed healthcare infrastructure, the growing prevalence of chronic ailments, and emerging health awareness among the public with increasing personal income. Advancements in technology and the absence of stringent regulation of POC procedures, coupled with a rapid paradigm shift towards self-care among patients with home-based testing options, are further driving the cardiac POC testing and kit market in this region.

However, healthcare reform and the deceleration of the economy in the U.S. have affected the growth of the market. Europe is predicted to secure the second position due to the increasing prevalence of chronic cardiac disorders, decentralized laboratories, the surging acceptance of POC devices in clinical care settings, and patient inclination to self-diagnosis. Cardiac POC testing devices resolve issues of patient admission in overcrowded hospitals and the shortage of properly skilled lab technicians in these regions.

Asia Pacific is anticipated to witness the fastest growth in the upcoming years on account of emerging economies, steady growth in health awareness, and developing healthcare infrastructure. Rising physician demand for POC procedures, a growing preference for long-term use of cardiac POC testing outside of a professional setting, and emerging regulatory guidelines are expected to fuel growth in this region in the upcoming period.

The complete regional classification of the global cardiac POC testing devices and kits market is as follows:

  • North America (U.S. and Canada)
  • Europe (Germany, the U.K., and the Rest of Europe)
  • Asia Pacific (China, India, Japan, and the Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East and Africa (GCC plus the rest of the Middle East and Africa) 

Frequently Asked Question:

The market for Cardiac POC Testing Devices and Kits Market is expected to reach USD$ 2.03 Bn in 2025.

The Cardiac POC Testing Devices and Kits Market is expected to see significant CAGR growth over the coming years, at 12.4%.

The report is forecasted to 2017-2025.

The base year of this report is 2016.

Nexus Dx, Inc., LifeSign LLC, Alfa Scientific Designs, Inc., Spectral Diagnostics, Roche Diagnostics International Ltd., American Screening Corporation, Inc., Alere, Abbott, Siemens Ltd., Mitsubishi Chemical, BioMérieux, Inc. are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Nov 2017
Category:  Medical Devices
Report ID:   58817
Report Format:   PDF
Pages:   120
Rating:    4.8 (60)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support